Anthrax PA Products

Antibodies
Anthrax PA Antibody
Anthrax PA Antibody
NB100-56670
Species: Ba
Applications: WB
Host: Rabbit Polyclonal
Formulation Catalog # Availability Price  

Description

Anthrax infection is initiated by the inhalation, ingestion, or cutaneous contact with Bacillus anthracis endospores. B. anthracis produces three polypeptides that comprise the anthrax toxin: protective antigen (PA), lethal factor (LF), and edema factor (EF) (1,2 for review). PA binds to two related proteins on the cell surface; these are termed tumor epithelial marker 8 (TEM8)/anthrax toxin receptor (ATR) (3) and capillary morphogenesis protein 2 (CMG2) (4), although it is still unclear which is physiologically relevant. Following PA binding to its receptor, PA is cleaved into two fragments by a furin-like protease. The bound fragment binds both LF and EF; the resulting complex is then endocytosed which allows the translocation of LF and EF into the cytoplasm (5). These toxins are usually sufficient to cause rapid cell death, and often the death of the organism.

Bioinformatics

Alternate Names
  • anthrax PA
  • Anthrax toxins translocating protein
  • Bacillus anthracis protective antigen
  • PA 83
  • PA
  • PA83
  • PAG
  • Paga
  • Protective antigen

Research Areas for Anthrax PA

Find related products by research area and learn more about each of the different research areas below.

Immunology
Virology, Bacteria and Parasites